100 mg/5 mL/bottle; 400 mg/20 mL/bottle
Darzalex (daratumumab injection) 100mg: 5mL; 400mg: 20mL
Daratumumab Injection
A public medicine summary is being prepared.
Public medicine directory
Antineoplastic and Immunomodulating Agents
Browse public medicine summaries, manufacturers, and approval information for Antineoplastic and Immunomodulating Agents.
1653 medicinesPage 107 of 138
1800 mg (15 mL)/bottle
Darzalex Faspro (daratumumab and hyaluronidase-fihj) 1800mg
Daratumumab Injection (Subcutaneous)
A public medicine summary is being prepared.
100 mg (5 mL)/vial; 400 mg (20 mL)/vial
Darzalex (daratumumab injection) 100mg; 400mg
Daratumumab Injection
A public medicine summary is being prepared.
1.0 mg/vial.